|
1
|
Portela A and Esteller M: Epigenetic
modifications and human disease. Nat Biotechnol. 28:1057–1068.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ballestar E: An introduction to
epigenetics. Adv Exp Med Biol. 711:1–11. 2011. View Article : Google Scholar
|
|
3
|
Illingworth RS and Bird AP: CpG islands -
‘a rough guide’. FEBS Lett. 583:1713–1720. 2009.
|
|
4
|
Guo SW: Epigenetics of endometriosis. Mol
Hum Reprod. 15:587–607. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bulun SE: Endometriosis. N Engl J Med.
360:268–279. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nasu K, Kawano Y, Tsukamoto Y, et al:
Aberrant DNA methylation status of endometriosis: epigenetics as
the pathogenesis, biomarker and therapeutic target. J Obstet
Gynaecol Res. 37:683–695. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martini M, Ciccarone M, Garganese G, et
al: Possible involvement of hMLH1, p16(INK4a) and PTEN in the
malignant transformation of endometriosis. Int J Cancer.
102:398–406. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu Y, Halverson G, Basir Z, Strawn E, Yan
P and Guo SW: Aberrant methylation at HOXA10 may be responsible for
its aberrant expression in the endometrium of patients with
endometriosis. Am J Obstet Gynecol. 193:371–380. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu Y, Strawn E, Basir Z, Halverson G and
Guo SW: Promoter hypermethylation of progesterone receptor isoform
B (PR-B) in endometriosis. Epigenetics. 1:106–111. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xue Q, Lin Z, Cheng YH, et al: Promoter
methylation regulates estrogen receptor 2 in human endometrium and
endometriosis. Biol Reprod. 77:681–687. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xue Q, Lin Z, Yin P, et al:
Transcriptional activation of steroidogenic factor-1 by
hypomethylation of the 5′ CpG island in endometriosis. J Clin
Endocrinol Metab. 92:3261–3267. 2007.PubMed/NCBI
|
|
12
|
Wang D, Chen Q, Zhang C, Ren F and Li T:
DNA hypomethylation of the COX-2 gene promoter is associated with
up-regulation of its mRNA expression in eutopic endometrium of
endometriosis. Eur J Med Res. 17:122012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu Y, Strawn E, Basir Z, Halverson G and
Guo SW: Aberrant expression of deoxyribonucleic acid
methyltransferases DNMT1, DNMT3A, and DNMT3B in women with
endometriosis. Fertil Steril. 87:24–32. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Izawa M, Taniguchi F, Uegaki T, Takai E,
Iwabe T, Terakawa N and Harada T: Demethylation of a nonpromoter
cytosine-phosphate-guanine island in the aromatase gene may cause
the aberrant up-regulation in endometriotic tissues. Fertil Steril.
95:33–39. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bulun SE, Cheng YH, Pavone ME, et al:
Estrogen receptor-beta, estrogen receptor-alpha, and progesterone
resistance in endometriosis. Semin Reprod Med. 28:36–43. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Grandien K: Determination of transcription
start sites in the human estrogen receptor gene and identification
of a novel, tissue-specific, estrogen receptor-mRNA isoform. Mol
Cell Endocrinol. 116:207–212. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Grandien K, Berkenstam A and Gustafsson
JA: The estrogen receptor gene: promoter organization and
expression. Int J Biochem Cell Biol. 29:1343–1369. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wen DX, Xu YF, Mais DE, Goldman ME and
McDonnell DP: The A and B isoforms of the human progesterone
receptor operate through distinct signaling pathways within target
cells. Mol Cell Biol. 14:8356–8364. 1994.PubMed/NCBI
|
|
19
|
Hirata S, Shoda T, Kato J and Hoshi K: The
multiple untranslated first exons system of the human estrogen
receptor beta (ER beta) gene. J Steroid Biochem Mol Biol. 78:33–40.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wills HJ, Reid GD, Cooper MJ and Morgan M:
Fertility and pain outcomes following laparoscopic segmental bowel
resection for colorectal endometriosis: a review. Aust NZ J Obstet
Gynaecol. 48:292–295. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
No authors listed. Revised American
Society for Reproductive Medicine classification of endometriosis.
Fertil Steril. 67:817–821. 1997. View Article : Google Scholar
|
|
22
|
Abrao MS, Neme RM, Carvalho FM, Aldrighi
JM and Pinotti JA: Histological classification of endometriosis as
a predictor of response to treatment. Int J Gynaecol Obstet.
82:31–40. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pires AR, da Matta Andreiulo F and de
Souza SR: TMA for all: a new method for the construction of tissue
microarrays without recipient paraffin block using custom-built
needles. Diagn Pathol. 1:142006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Negraes PD, Favaro FP, Camargo JL,
Oliveira ML, Goldberg J, Rainho CA and Salvadori DM: DNA
methylation patterns in bladder cancer and washing cell sediments:
a perspective for tumor recurrence detection. BMC Cancer.
8:2382008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sasaki M, Tanaka Y, Perinchery G, Dharia
A, Kotcherguina I, Fujimoto S and Dahiya R: Methylation and
inactivation of estrogen, progesterone, and androgen receptors in
prostate cancer. J Natl Cancer Inst. 94:384–390. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Neve RM, Chin K, Fridlyand J, et al: A
collection of breast cancer cell lines for the study of
functionally distinct cancer subtypes. Cancer Cell. 10:515–527.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gu F, Doderer MS, Huang YW, et al: CMS: a
web-based system for visualization and analysis of genome-wide
methylation data of human cancers. PLoS One. 8:e609802013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dai D, Wolf DM, Litman ES, White MJ and
Leslie KK: Progesterone inhibits human endometrial cancer cell
growth and invasiveness: down-regulation of cellular adhesion
molecules through progesterone B receptors. Cancer Res. 62:881–886.
2002.
|
|
29
|
Wu Y, Shi X and Guo SW: The knockdown of
progesterone receptor isoform B (PR-B) promotes proliferation in
immortalized endometrial stromal cells. Fertil Steril.
90:1320–1323. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brandenberger AW, Lebovic DI, Tee MK, Ryan
IP, Tseng JF, Jaffe RB and Taylor RN: Oestrogen receptor (ER)-alpha
and ER-beta isoforms in normal endometrial and
endometriosis-derived stromal cells. Mol Hum Reprod. 5:651–655.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fujimoto J, Hirose R, Sakaguchi H and
Tamaya T: Expression of oestrogen receptor-alpha and -beta in
ovarian endometriomata. Mol Hum Reprod. 8:742–747. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Leader JE, Wang C, Popov VM, Fu M and
Pestell RG: Epigenetics and the estrogen receptor. Ann NY Acad Sci.
1089:73–87. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ström A, Hartman J, Foster JS, Kietz S,
Wimalasena J and Gustafsson JA: Estrogen receptor beta inhibits
17beta-estradiol-stimulated proliferation of the breast cancer cell
line T47D. Proc Natl Acad Sci USA. 101:1566–1571. 2004.PubMed/NCBI
|
|
34
|
Taylor SE, Martin-Hirsch PL and Martin FL:
Oestrogen receptor splice variants in the pathogenesis of disease.
Cancer Lett. 288:133–148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Flouriot G, Griffin C, Kenealy M,
Sonntag-Buck V and Gannon F: Differentially expressed messenger RNA
isoforms of the human estrogen receptor-alpha gene are generated by
alternative splicing and promoter usage. Mol Endocrinol.
12:1939–1954. 1998.
|
|
36
|
Lu B, Leygue E, Dotzlaw H, Murphy LJ,
Murphy LC and Watson PH: Estrogen receptor-beta mRNA variants in
human and murine tissues. Mol Cell Endocrinol. 138:199–203. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu B, Dotzlaw H, Leygue E, Murphy LJ,
Watson PH and Murphy LC: Estrogen receptor-alpha mRNA variants in
murine and human tissues. Mol Cell Endocrinol. 158:153–161. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ottaviano YL, Issa JP, Parl FF, Smith HS,
Baylin SB and Davidson NE: Methylation of the estrogen receptor
gene CpG island marks loss of estrogen receptor expression in human
breast cancer cells. Cancer Res. 54:2552–2555. 1994.PubMed/NCBI
|
|
39
|
Lapidus RG, Nass SJ and Davidson NE: The
loss of estrogen and progesterone receptor gene expression in human
breast cancer. J Mammary Gland Biol Neoplasia. 3:85–94. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sharma D, Saxena NK, Davidson NE and
Vertino PM: Restoration of tamoxifen sensitivity in estrogen
receptor-negative breast cancer cells: tamoxifen-bound reactivated
ER recruits distinctive corepressor complexes. Cancer Res.
66:6370–6378. 2006. View Article : Google Scholar
|
|
41
|
Macaluso M, Montanari M, Noto PB, Gregorio
V, Bronner C and Giordano A: Epigenetic modulation of estrogen
receptor-alpha by pRb family proteins: a novel mechanism in breast
cancer. Cancer Res. 67:7731–7737. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sharma D, Blum J, Yang X, Beaulieu N,
Macleod AR and Davidson NE: Release of methyl CpG binding proteins
and histone deacetylase 1 from the estrogen receptor alpha (ER)
promoter upon reactivation in ER-negative human breast cancer
cells. Mol Endocrinol. 19:1740–1751. 2005. View Article : Google Scholar
|
|
43
|
Rody A, Holtrich U, Solbach C, et al:
Methylation of estrogen receptor beta promoter correlates with loss
of ER-beta expression in mammary carcinoma and is an early
indication marker in premalignant lesions. Endocr Relat Cancer.
12:903–916. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhao L, Yu Z, Li Y, et al: Clinical
implications of ERβ methylation on sporadic breast cancers in
Chinese women. Med Oncol. 29:1569–1575. 2012.
|
|
45
|
Han H, Cortez CC, Yang X, Nichols PW,
Jones PA and Liang G: DNA methylation directly silences genes with
non-CpG island promoters and establishes a nucleosome occupied
promoter. Hum Mol Genet. 20:4299–4310. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zelenko Z, Aghajanova L, Irwin JC and
Giudice LC: Nuclear receptor, coregulator signaling, and chromatin
remodeling pathways suggest involvement of the epigenome in the
steroid hormone response of endometrium and abnormalities in
endometriosis. Reprod Sci. 19:152–162. 2012. View Article : Google Scholar
|
|
47
|
Laird PW: The power and the promise of DNA
methylation markers. Nat Rev Cancer. 3:253–266. 2003. View Article : Google Scholar : PubMed/NCBI
|
